Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol

Malaria Journal

Table 2 Percentage of health facilities with the required resources for implementation of the new national malaria treatment protocol

Resource	Health centre		Aid post		Overall
	%	(95% CI)	%	(95% CI)	%	(95% CI)
Diagnostic Test
RDT	90.2	(76.9, 97.3)	21.3	(10.7, 35.7)	53.4	(42.5, 64.1)
Microscopy^a,	7.3	(1.5, 19.9)	2.1	(<0.1, 11.3)	4.6	(1.3, 11.2)
RDT or microscopy	90.2	(76.9, 97.3)	21.3	(10.7, 35.7)	53.4	(42.5, 64.1)
Recommended medication – first- and second-line treatment ^b
AL^c, all categories	87.8	(73.8, 95.9)	19.2	(9.1, 33.3)	51.1	(40.2, 61.9)
AL, 5–15 kg	95.1	(83.5, 99.4)	21.3	(10.7, 35.7)	55.7	(44.7, 56.3)
AL, 15-25 kg	92.7	(80.1, 98.5)	23.4	(12.3, 38.0)	55.7	(44.7, 56.3)
AL, 25–35 kg	92.7	(80.1, 98.5)	19.2	(9.1, 33.3)	53.4	(42.5, 64.1)
AL, 35+ kg	92.7	(80.1, 98.5)	23.4	(12.3, 38.0)	55.7	(44.7, 56.3)
AL + PQ^d	68.3	(51.9, 81.9)	14.9	(6.2, 28.3)	39.8	(29.5, 50.1)
DP^e	4.9	(<0.1, 16.5)	0	-	2.3	(<0.1, 8.0)
AI + AL^f	70.7	(54.5, 83.9)	8.5	(2.4, 20.4)	37.5	(27.4, 48.5)
AI + AL + PQ^g	61.0	(44.5, 75.8)	8.5	(2.4, 20.4)	33.0	(23.3, 43.8)
QI + QT + DX^h	65.9	(49.4, 79.9)	29.8	(17.3, 44.9)	46.6	(35.9, 57.5)
Selected ‘other’ anti-malarial medication
SP	97.6	(87.1, 99.9)	87.2	(74.3, 95.2)	92.1	(84.3, 96.7)
CQ	92.7	(80.1, 98.5)	85.1	(71.7, 93.8)	88.6	(80.1, 94.4)
AQ	92.7	(80.1, 98.5)	87.2	(74.3, 95.2)	89.8	(81.5, 95.2)
Artemether tablets	68.3	(51.9, 81.9)	42.6	(28.3, 57.8)	54.6	(43.6, 65.2)

^aMicroscopy was defined as the presence of a functional microscope, all essential supplies (Giemsa stain, slides and, in the case of electric microscopes, power) and a trained microscopist in employment.
^bThe quantity of each medication was not accounted for in this analysis; rather, the data represent the percentage of health facilities that had at least one vial or container (inclusive of a single, opened container) of the respective anti-malarial in stock.
^cFirst-line treatment for uncomplicated P. falciparum infection.
^dFirst-lline treatment for uncomplicated P. vivax infection.
^eSecond-line treatment for uncomplicated malaria infection.
^fFirst-line treatment for severe P. falciparum infection.
^gFirst-line treatment for severe P. vivax infection.
^hSecond-line treatment for severe malaria infection.
AL = artemether-lumefantrine, PQ = primaquine, DP = dihydroartemisinin-piperaquine, AI = artemether or artesunate injection, QI = quinine injection, QT = quinine tablets, DX = doxycycline, SP = sulphadoxine-pyrimethamine, CQ = chloroquine, AQ = amodiaquine.

ISSN: 1475-2875